SBI Okasan Asset Management Co.Ltd. Takes Position in Danaher Corporation $DHR

SBI Okasan Asset Management Co.Ltd. acquired a new stake in Danaher Corporation (NYSE:DHR) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,100 shares of the conglomerate’s stock, valued at approximately $1,637,000.

Other large investors also recently modified their holdings of the company. Tyche Wealth Partners LLC acquired a new stake in Danaher during the third quarter worth approximately $462,000. Bank Pictet & Cie Europe AG grew its position in Danaher by 25.4% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after buying an additional 74,301 shares in the last quarter. Johnson Investment Counsel Inc. grew its position in Danaher by 2.9% during the third quarter. Johnson Investment Counsel Inc. now owns 664,705 shares of the conglomerate’s stock worth $131,784,000 after buying an additional 18,744 shares in the last quarter. Guinness Asset Management LTD grew its stake in Danaher by 13.7% during the third quarter. Guinness Asset Management LTD now owns 223,570 shares of the conglomerate’s stock worth $41,597,000 after buying an additional 26,896 shares in the last quarter. Finally, AlphaQuest LLC grew its stake in Danaher by 896.1% during the third quarter. AlphaQuest LLC now owns 5,598 shares of the conglomerate’s stock worth $1,110,000 after buying an additional 5,036 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Up 4.2%

Shares of DHR opened at $180.47 on Friday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The stock has a market capitalization of $127.73 billion, a price-to-earnings ratio of 34.91, a PEG ratio of 2.31 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The stock has a fifty day moving average of $182.29 and a 200-day moving average of $207.65.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period last year, the company earned $1.88 earnings per share. As a group, sell-side analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on DHR shares. Royal Bank Of Canada started coverage on shares of Danaher in a research note on Thursday, May 14th. They set an “outperform” rating and a $200.00 price objective on the stock. Citigroup initiated coverage on shares of Danaher in a research note on Tuesday. They set a “buy” rating and a $230.00 price objective on the stock. Robert W. Baird reduced their target price on Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a report on Friday, April 17th. Argus reduced their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Friday, April 24th. Finally, Evercore raised their target price on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a report on Tuesday, April 21st. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $238.24.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.